W., P., T., C., E., C., N., V., K., L., & K., C. (2017). Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation.

W., Prasitsuebsai, Cressey T., Capparelli E., Vanprapar N., Lapphra K., and Chokephaibulkit K. Pharmacokinetics of Nevirapine in HIV and Tuberculosis-coinfected Children Receiving Antiretroviral Fixed-dose Combination Tablets While Receiving Rifampicin-containing Tuberculosis Treatment and After Rifampicin Discontinuation. 2017.

W., Prasitsuebsai, et al. Pharmacokinetics of Nevirapine in HIV and Tuberculosis-coinfected Children Receiving Antiretroviral Fixed-dose Combination Tablets While Receiving Rifampicin-containing Tuberculosis Treatment and After Rifampicin Discontinuation. 2017.